Who has invested in Innolake Biopharm?

WuXi Biologics, Qiantang Industrial Group, Zhongbo Juli are named among the investors backing Innolake Biopharm.

Innolake Biopharm Funding: $76M Raised, Pre-A (2021)

Innolake Biopharm funding overview

Innolake Biopharm is based in China. Innolake Biopharm has raised $76M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Pre-A announced in April 2021. The round record for Innolake Biopharm runs through 2021; nothing later has been disclosed. Investors on record include WuXi Biologics, Qiantang Industrial Group, Zhongbo Juli. 3 distinct backers are named across the disclosed rounds.

Innolake Biopharm at a glance

Total raised: $76M
Latest round: Pre-A
Latest round date: April 2021
Headquarters: China
Notable investors: WuXi Biologics, Qiantang Industrial Group, Zhongbo Juli

Frequently asked about Innolake Biopharm funding

How much has Innolake Biopharm raised?: Innolake Biopharm has raised $76M in total disclosed funding across the rounds on record.
Who has invested in Innolake Biopharm?: WuXi Biologics, Qiantang Industrial Group, Zhongbo Juli are named among the investors backing Innolake Biopharm.
What was the latest Innolake Biopharm funding round?: The most recent disclosed round is a Pre-A, announced in April 2021.
Where is Innolake Biopharm based?: Innolake Biopharm is based in China.
When did Innolake Biopharm last raise?: The last disclosed Innolake Biopharm round closed in April 2021 at Pre-A.

Innolake Biopharm totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in China below to benchmark round size and investor mix.

Innolake Biopharm Funding: $76M Raised, Pre-A (2021)

Innolake Biopharm funding overview

Innolake Biopharm at a glance

Frequently asked about Innolake Biopharm funding

Companies related to Innolake Biopharm (20)

Browse related funding lists (2)